Compass Pathways · 3 days ago
Director, Product Communications
New York, United States
Full-time
Hybrid
Director/Executive
$190K/yr - $240K/yr
10+ years expCompass Pathways is a biotechnology company focused on accelerating patient access to innovative mental health treatments. The Director of Product Communications will lead the development and execution of communication strategies for the company's pipeline and future assets, ensuring consistent and impactful messaging across various channels.
BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
No H1B
Responsibilities
Lead the development and implementation of comprehensive product communication strategies to support our investigational product through Phase 3 data readouts, regulatory filings, and potential commercial launch
Design and execute global communications programs that articulate the scientific and clinical value of our pipeline to media, HCPs, and patient communities, ensuring alignment with Compass's corporate narrative
Partner with cross-functional teams including Commercial, Medical Affairs, Regulatory, and Legal to ensure all communications are compliant, accurate, and strategically aligned with business objectives
Enable internal organizational alignment by communicating product milestones and strategies to employees, fostering a sense of shared purpose
Establish and manage relationships with key trade, healthcare and consumer journalists
Develop high-impact materials including press releases, Q&As, key message documents, for clinical milestones and congresses
Lead crisis and issues management related to product candidates, proactively anticipating reputational risks and developing mitigation strategies in a complex regulatory environment
Build and execute communications plans for launch readiness, creating disease state awareness campaigns in partnership with cross-functional team members that reduce stigma and educate stakeholders on treatment-resistant depression (TRD) and PTSD
Collaborate with the Medical Affairs and Scientific Communications teams to amplify data dissemination at major medical congresses and through peer-reviewed publications
Drive the narrative for patient access and value, supporting Market Access teams with communications that address payer and health system dynamics
Qualification
Required
Over 10 years of experience in pharmaceutical/biotech communications or public relations
Proven track record leading product communications for a product launch, ideally as a first-in-class
Deep understanding of FDA/EMA regulations regarding drug promotion and scientific exchange
Expertise in media relations with established contacts in biotech, healthcare and consumer sectors
Proven track record of being an out-of-the-box and highly creative thinker, adept at building unique plans that reach stakeholders in new and different ways
Cross-functional collaborator with excellent communication skills, able to navigate a matrixed environment across Commercial, Medical, and IR
Adept at managing external public relations agencies and vendors, ensuring budget efficiency and high-quality execution of tactical plans
Hands-on builder capable of setting strategy while executing tactical deliverables in a fast-paced, growth-stage environment
Degree in Communications or Journalism
Mission-aligned, inclusive leader reflecting Compass's wellbeing-first, stigma free culture
Demonstrates Compass' values: Compassion, Boldness, Inclusion, Rigour
Preferred
Agency and in-house experience preferred
CNS/psychiatry preferred
Advanced degree preferred
Company
Compass Pathways
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$421.21MKey Investors
Hercules CapitalMcQuade Center for Strategic Research and Development
2025-01-10Post Ipo Equity· $150M
2023-08-16Post Ipo Equity· $125M
2023-07-05Post Ipo Debt· $30M
Leadership Team
Kabir Nath
Chief Executive Officer
Teri loxam
Chief Financial Officer
Recent News
2026-01-12
2026-01-08
Company data provided by crunchbase